Bladder cancer is a global health issue with sex differences in incidence and prognosis.
Bladder cancer has distinct molecular subtypes with multiple pathogenic pathways …

Non-muscle-invasive bladder cancer (NMIBC) is an early-stage cancer without invasion into
the detrusor muscle layer. Transurethral resection of bladder tumour (TURBT) is a diagnostic …

This selection from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)
for Bladder Cancer focuses on the clinical presentation and workup of suspected bladder …

Diagnostic pathology is the foundation and gold standard for identifying carcinomas.
However, high inter-observer variability substantially affects productivity in routine pathology …

Chemotherapy is a reasonable alternative to cystectomy in patients with invasive and
advanced bladder cancer. However, bladder cancer cells often develop drug resistance to …

It is estimated that 74,000 people in the United States and roughly 386,000 people globally
will be newly diagnosed with bladder cancer in 2015. 1, 2 Bladder cancer represents a …

Long non-coding RNAs (lncRNAs) play important roles in diverse biological processes, such
as transcriptional regulation, cell growth and tumorigenesis. However, little is known about …

Many patients diagnosed with muscle-invasive bladder cancer (MIBC) will develop distant
metastatic disease. Over the past three decades, perioperative cisplatin-based …

Purpose Despite being one of the most important clinical outcomes in nonmuscle invasive
bladder cancer, there is currently no standard definition of disease progression. Major …

Onco-miR-182-5p has been reported to be over-expressed in bladder cancer (BC) tissues
however a detailed functional analysis of miR-182-5p has not been carried out in BC …